473PInfluence of the proton pump inhibitor esomeprazole on the bioavailability of regorafenib. (23rd October 2018) - de Man, F M; Hussaarts, K G A M; de With, M; Oomen-De Hoop, E; van Halteren, H K; van der Burg-De Graauw, N C H P; Eskens, F A L M; van Gelder, T; van Leeuwen, R W F; Mathijssen, R H J